Clinical Trials Sponsored by NovImmune SA

Total 1038 results

Light Chain Bioscience - Novimmune SA

Recruiting

A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers

Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-squamous Non-small-cell Lung Cancer

Italy, France
Light Chain Bioscience - Novimmune SA

Completed

Study of an Anti-TLR4 mAb in Rheumatoid Arthritis

Rheumatoid Arthritis

Serbia, Bosnia and Herzegovina, Bulgaria, Georgia, Hungary, Moldova, Republic of, Poland
Light Chain Bioscience - Novimmune SA

Completed

First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers (NI-0101-01)

Healthy Volunteers

Netherlands
Light Chain Bioscience - Novimmune SA

Completed

NI-0401 in Active Crohn's Disease

Moderate to Severe Crohn's Disease
Light Chain Bioscience - Novimmune SA

Terminated

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (PIANO)

Primary Biliary Cirrhosis

Italy, United Kingdom
Light Chain Bioscience - Novimmune SA

Completed

NI-0801 in Allergic Contact Dermatitis

Allergic Contact Dermatitis
Light Chain Bioscience - Novimmune SA

Completed

NI-0401 in Patients With Acute Renal Allograft Rejection

Acute Renal Transplant Rejection

France
Light Chain Bioscience - Novimmune SA

Completed

First in Human Study of NI-0701 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Swedish Orphan Biovitrum
Light Chain Bioscience - Novimmune SA

Terminated

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

Hemophagocytic Lymphohistiocytoses

United States
Light Chain Bioscience - Novimmune SA
M.D. Anderson Cancer Center

Completed

Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)

Hemophagocytic Lymphohistiocytosis

United States
CoImmune

Terminated

Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

United States
NexImmune Inc.

Not yet recruiting

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Oropharyngeal Cancer | Human Papilloma Virus | Head and Neck Cancer Metastatic | HPV-Related Squamous Cell Carcinoma | Oropharyngeal Cancer, Metastatic | HPV-Related Mucosal Head and Neck Squamous... and other conditions
NexImmune Inc.

Suspended

Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma

Relapsed Refractory Multiple Myeloma

United States
NexImmune Inc.

Active, not recruiting

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
NImmune Biopharma

Completed

Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

Ulcerative Colitis

United States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
NImmune Biopharma

Withdrawn

Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis

Eosinophilic Esophagitis
NImmune Biopharma

Completed

Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers

Normal Healthy Volunteers

United States
NImmune Biopharma

Terminated

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

Crohn's Disease

United States
NImmune Biopharma

Completed

Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers

Normal Healthy Volunteers

Australia
NImmune Biopharma

Withdrawn

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Crohn's Disease
NatImmune A/S

Unknown

bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients

Cutaneous Warts

Denmark
Revimmune
Amarex Clinical Research

Terminated

InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort (ILIAD-7-UK)

COVID-19 | Lymphocytopenia

United Kingdom
Aptissen SA

Not yet recruiting

6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

Osteoarthritis, Hip

France
Aktiia SA

Recruiting

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Hypertension | Blood Pressure | Heart Rate

Switzerland
Firalis SA

Not yet recruiting

Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers

Healthy

France
Amazentis SA

Recruiting

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Healthy | Healthy Aging | Healthy Diet

United States
Axalbion SA

Recruiting

A Study of Efficacy and Safety of AX-8 in Chronic Cough

Chronic Cough

United Kingdom
Cellaion SA

Active, not recruiting

Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF) (DHELIVER)

Acute on Chronic Liver Failure

Belgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
Teoxane SA

Completed

RHA® 3 Versus Restylane-L® for Lip Augmentation

Lip | Lip Augmentation

United States
Maxivax SA

Active, not recruiting

MVX-ONCO-1 in Patients With Solid Tumor

Cancer | Solid Tumor

Switzerland
Poxel SA

Completed

Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)

NASH - Nonalcoholic Steatohepatitis

United States
Anokion SA

Active, not recruiting

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (MoveS-it)

Relapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)

United States
Amazentis SA

Completed

Detection of Gut Metabolites in Mother's Milk Following Juice Intake

Healthy Diet

United States
Phargentis SA

Completed

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

COPD

United States, India, Switzerland
Teoxane SA

Completed

RHA® 4 NLF Cannula

Aging | Wrinkle | Nasolabial Fold

United States
Cryotherapeutics SA

Withdrawn

Pilot Study on the Effect of Intracoronary Cryotherapy on Stabilization of Vulnerable Plaque at Risk of Rupture (ICEBERG)

Acute Coronary Syndrome

Denmark, Sweden
Abionic SA

Completed

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Sepsis | Sepsis Bacterial

France
Stalicla SA

Completed

Characterization of a Clinical Subpopulation With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Stalicla SA

Withdrawn

Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
ObsEva SA

Completed

A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis (EDELWEISS)

Endometriosis

United States, Poland, Russian Federation, Ukraine
Sintetica SA

Completed

Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Healthy Volunteers

Austria
Stalicla SA

Completed

Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Sintetica SA

Completed

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Healthy Subjects

Switzerland
Firalis SA

Active, not recruiting

HeartLinc, a Study With AMI Patients Undergoing PCI (HeartLinc)

AMI Patients

France, Korea, Republic of
Spineart SA

Terminated

ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP (ROMEO 2 PAD FR)

Spinal Disease

France
Anecova SA

Completed

Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study

Endometrial Fluid

Spain
Pharnext SA

Completed

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)

Charcot-Marie-Tooth Disease Type 1A

United States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
Combioxin SA

Completed

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

Pneumonia | Pneumococcal Infections

France, Belgium
ObsEva SA

Completed

Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Hepatic Impairment | Healthy Participants

United States
PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIV)

Uterine Fibroids

United Kingdom, Belgium, Czechia, France, Germany, Hungary, Italy, Latvia, Lithuania, Romania, Ukraine

Clinical Trials Sponsored by NovImmune SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations